Rationale for Treatment of mNSCLC with Immune Checkpoint Inhibitors

Video

Dr Edward B. Garon explains the rationale for treating patients with mNSCLC with a frontline combination of chemotherapy and immune checkpoint inhibitors.

Recent Videos
Mazyar Shadman, MD, MPH, an expert on CLL
Mazyar Shadman, MD, MPH, an expert on CLL
Martin H. Voss, MD, an expert on kidney cancer
Martin H. Voss, MD, an expert on kidney cancer
Martin H. Voss, MD, an expert on kidney cancer
Martin H. Voss, MD, an expert on kidney cancer
Martin H. Voss, MD, an expert on kidney cancer
Guillermo Garcia-Manero, MD, an expert on MDS
Related Content